---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-262161"
form_type: "8-K"
ticker: "ABOS"
cik: "0001576885"
company_name: "Acumen Pharmaceuticals, Inc."
filed_at: "2021-08-31T23:59:59+00:00"
generated_at: "2026-06-29T06:45:15.036667+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Acumen posts updated corporate presentation; no specific financial data disclosed

## Summary
- Updated corporate presentation posted to investor website on August 31, 2021.
- Presentation may be used in upcoming investor communications and conferences.
- No quarterly results, guidance, or material business developments were disclosed in the filing.

## SEC filing metadata
- accession: 0001193125-21-262161
- form_type: 8-K
- ticker: ABOS
- cik: 0001576885
- company_name: Acumen Pharmaceuticals, Inc.
- filed_at: 2021-08-31T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1576885/000119312521262161/0001193125-21-262161-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1576885/000119312521262161/d189880d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-262161
- JSON: https://secwatch.observer/filing/0001193125-21-262161.json
- Plain text: https://secwatch.observer/filing/0001193125-21-262161.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.